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Abstract
Background: Volume substitution remains subject of controversy in the light of effusions and oedema potentially
complicating this highly febrile disease. Understanding the role of myocardial and circulatory function appears to
be essential for clinical management. In the present study, cardiac function and cardiac proteins have been
assessed and correlated with parasitological and immunologic parameters in patients with imported Plasmodium
falciparum malaria.
Methods: In a prospective case-control study, 28 patients with uncomplicated and complicated P. falciparum
malaria were included and findings were compared with 26 healthy controls. Cardiac function parameters were
assessed by an innovative non-invasive method based on the re-breathing technique. In addition, cardiac enzymes
and pro- and anti-inflammatory cytokines were measured and assessed with respect to clinical symptoms and
conditions of malaria.
Results: Cardiac index (CI) as a measurement of cardiac output (CO) was 21% lower in malaria patients than in
healthy controls (2.7 l/min/m
2 versus 3.4 l/min/m
2; P < 0.001). In contrast, systemic vascular resistance index (SVRI)
was increased by 29% (32.6 mmHg⋅m
2/(l/min) versus 23.2 mmHg⋅m
2/(l/min); P < 0.001). This correlated with
increased cardiac proteins in patients versus controls: pro-BNP 139.3 pg/ml versus 60.4 pg/ml (P = 0.03), myoglobin
43.6 μg/l versus 27.8 μg/l (P = < 0.001). All measured cytokines were significantly increased in patients with
malaria. CI, SVRI as well as cytokine levels did not correlate with blood parasite density.
Conclusions: The results support previous reports suggesting impaired cardiac function contributing to clinical
manifestations in P. falciparum malaria. Findings may be relevant for fluid management and should be further
explored in endemic regions.
Background
Circulatory collapse and symptoms associated with
impaired hemodynamic function are characteristics of
complicated Plasmodium falciparum malaria [1]. While
impaired cardiac function has long been established as a
key component of bacterial sepsis and septic shock, the
role of the heart in severe malaria has only recently
been started to be further explored. Ehrhardt et al have
shown that cardiac enzymes are elevated in complicated
malaria [2,3]. Ejection fraction assessed by ultrasound in
children with severe malaria was significantly reduced
on admission compared with discharge [4].
In sepsis, reduced pre-load, myocardial suppression as
well as reduced after-load contribute to hyperdynamic
but insufficient cardiac function resulting in tachycardia
and hypotension. Both, direct toxic effects of bacterial
agents as well as excessive production of cytokines and
immune mediators have been identified to cause this
dysfunction [5-7]. Rapid and abundant rehydration, use
of catecholamines for positive inotropic cardiac support
as well as peripheral vasoconstriction are well-estab-
lished therapeutic options. In contrast, some pathome-
chanisms like parasite sequestration in small vessels and
capillary leakage associated with the risk of effusions
and oedema are malaria-specific, while other features
such as disturbed microcirculation and lactic acidosis as
well as excessive production of pro-inflammatory cyto-
kines, are similar in malaria and bacterial sepsis [8,9].
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and to which extent volume substitution should be
recommended in malaria patients [10,11].
Severe malaria is still a leading cause of death espe-
cially in children in sub-Saharan Africa. Mortality rates
of severe malaria in these regions remain high as anti-
parasitic treatment is often insufficient to prevent fatal
outcome. Understanding the role of the heart in clinical
manifestation of malaria is essential to improve fluid
management and symptomatic treatment for this often
enough fatal disease.
While biochemical markers and ultrasound findings
suggest cardiac impairment in severely ill children with
P. falciparum malaria [2-4,12], more accurate assess-
ment of cardiac function in malaria is difficult to per-
form either because invasive monitoring is not indicated
or because it is impractical in hospital settings of devel-
oping countries. Furthermore, no studies have been per-
formed to date on patients with uncomplicated malaria.
In this study, an innovative non-invasive method was
used to assess cardiac output in travellers returning with
P. falciparum malaria. In addition, cardiac enzymes and
pro- and anti-inflammatory cytokines were analysed.
Findings were compared in an unmatched case-control
approach.
Methods
Study population
Between June 2007 and May 2008, patients hospitalized
for P. falciparum malaria at the University Medical Cen-
tre Hamburg-Eppendorf, Section Tropical Medicine,
were included. Patients above 18 years of age were eligi-
ble for participation if they had no known illness or her-
editary malformation related to the heart influencing
cardiac function and no known lung disease. Patients
were clinically examined, blood samples were obtained
and cardiac function was assessed within 24 hours after
hospital admission. Plasmodium falciparum malaria was
defined as presence of asexual blood stage parasites and
no evidence for other infectious diseases. Complicated
malaria was defined according to national guidelines by
the German Society for Tropical Medicine [13]. Briefly,
complicated malaria is defined as the presence of at least
one of the following criteria: i) impaired consciousness,
ii) hypoglycaemia (blood glucose < 40 mg/dl), iii) clinical
signs of circulatory collapse, iv) spontaneous bleeding, v)
acidosis (base deficit > 8 mmol/l), vi) hyperbilirubinae-
mia/jaundice (bilirubin > 3 mg/dl), vii) anaemia (haemo-
globin < 8 g/dl), viii) renal insufficiency (creatinine > 2.5
mg/dl), ix) hyperparasitaemia (> 5% parasitized red blood
cells), and x) elevated transaminases (> 3x above upper
limit). Antiparasitic treatment was started accordingly
with either mefloquine, artemether-lumefantrine or a
quinine-doxycyclin combination including usual
supportive care as clinically indicated. In an unmatched
case-control design, unrelated healthy German adults
without clinical signs of ongoing infectious disease or
known cardiac or pulmonary disease served as controls.
Approval of the local ethics committee was obtained and
written informed consent was obtained from each patient
and control subject.
Parasitology, blood chemistry
Plasmodium falciparum malaria was ascertained from
Giemsa-stained thick and thin blood films. Routine
laboratory parameters including differential blood count,
creatinine, total bilirubin and lactate dehydrogenase
( L D H )w e r em e a s u r e da tt h ec e n t r a lu n i v e r s i t yl a b o r a -
tory according to standardized procedures. The analysis
of the cardiac proteins N-terminal pro-brain natriuretic
peptide (NT-proBNP), myoglobin, creatine kinase-mus-
cle brain (CK-MB), and troponin T (TnT) was also per-
formed as part of the routine panel at the central
university laboratory. Heart-type fatty acid-binding pro-
tein (H-FABP) was determined by enzyme-linked immu-
nosorbent assay (Abcam Ltd.
®,C a m b r i d g e ,U K ) .F r o m
all patients and controls, additional serum samples were
obtained and stored at -80°C until further analysis of
cytokines.
Assessment of cardiac function
In addition to clinical symptoms and conditions defining
severe malaria [1,13], cardiac function was assessed by a
non-invasive method based on a single-alveolar lung
model. This method has been evaluated in several inde-
pendent investigations [e.g. 14, 15]. The principle of this
method is based on re-breathing a gas mixture and cal-
culating the pulmonary blood flow from the dilution of
a soluble gas. It is assumed that (i) gases within alveolar
and dead space air as well as the bag volume mix com-
pletely and instantaneously, (ii) instantaneous equili-
brium of soluble gas between alveoli and blood and
between alveoli and tissue occurs, respectively, (iii) con-
stant pulmonary blood flow (PBF) and constant lung
volume of lung tissues given, and (iv) mixed venous
concentration of soluble gas throughout the re-breathing
period is negligible. For the latter assumption, it is
required that no re-circulation (shunt) occurs and
repeated measurements are carried out after sufficient
washout periods (e.g. 5 minutes). During the re-breath-
ing period, the concentration of an insoluble gas (sul-
phur hexafluoride, SF6) decreases from the initial value
in the bag (Fi
0) to a final equilibrium (Fi,eq) value practi-
cally obtained after a few breaths. Since the volume of
the re-breathing bag is known, the total ventilated
volume can be determined from the dilution of the inso-
luble gas. The nearly instantaneous disappearance of the
soluble gas nitrous oxide (N2O) is ascribed to solution
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portional to the pulmonary blood flow. Assuming a con-
stant PBF and a constant total ventilated volume, the
disappearance curve for the soluble gas describes a
monoexponentially decreasing function of time since the
rate of absorption is also proportional to the alveolar
gas concentration. Pulmonary blood flow is then calcu-
lated. Cardiac output can be derived from pulmonary
blood flow after correction for intrapulmonary shunt
fraction. By including parameters like blood pressure,
heart rate, peripheral oxygen saturation, weight and
height, further parameters like stroke volume and sys-
temic vascular resistance were calculated. To account
for differences in height and weight, measurements for
cardiac output (CO, [ml/min]), stroke volume (SV, [ml])
and systemic vascular resistance (SVR, [ mmHg/(l/
min)]) were related to the body surface [m
2] and respec-
tive cardiac-, stroke- and systemic vascular resistance
indices (CI, SI, SVRI) were included into statistical ana-
lyses. Patients did not receive volume infusions shortly
before or during the re-breathing measurements.
Cytokine analysis
Sera of the patients were analysed for pro- and anti-
inflammatory cytokines with a Cytokine Bead Array fol-
lowing manufacturer instructions (Becton Dickinson
®
(BD) Biosciences, Heidelberg, Germany). The following
cytokines were measured: IL-2, IL-6, TNF-a, IFN-g (Th-
1 response), IL-4, IL-10 (Th2-response), and IL-17A
(Th-17 response). Briefly, phycoerythrin (PE)-conjugated
(emission maximum 575 nm; FL2) beads with distinct
PE fluorescence intensities which have been coated with
capture antibodies specific for the various cytokines
were mixed with serum enhancement buffer and recom-
binant cytokine standards (20-5000 pg/ml) or patients
serum samples. After centrifugation at 200 g for 5 min
the supernatants were aspirated and discarded. After
incubation of the beads for 3 h with a PE detection
reagent at room temperature, wash buffer was added
and the suspension centrifuged as before. After discard-
ing the supernatant the beads were resuspended in wash
buffer for acquiring and analysis of the samples in a
flow cytometer (FACS Calibur
®, BD) applying BD Cell-
Quest
® software.
Statistics
The SPSS 17.0 software package (SPSS Inc.
® Chicago,
IL, USA) was used for statistical analysis. Normal distri-
bution was assessed by the Kolmogorov-Smirnov test.
The independent sample t-test or the Mann-Whitney
U-test were used to assess differences between cases
and controls, as appropriate. Proportions were assessed
by chi-square test or Fisher’s exact test (two-tailed) as
applicable. For correlation of cardiac function tests and
cytokines Pearson correlation test was used. Statistical
significance was considered a P < 0.05.
Results
Baseline characteristics
Cardiac function, serologicala n dp a r a s i t o l o g i c a lp a r a -
meters were investigated in 28 patients with imported P.
falciparum malaria. All patients screened within the
study period were found to be eligible according to the
study protocol. Eighteen patients were African migrants
whose reason to travel was visiting friends and relatives
in their home countries and 10 German expatriates/
tourists. All patients originating from endemic countries
had lived in Germany for at least two years prior to
recent travel to endemic regions. Cases consisted of 21
patients with uncomplicated malaria and 7 cases of
complicated malaria. Criteria for complicated malaria
were hyperbilirubinaemia (> 3 mg/dl, 5 cases), acute
renal insufficiency (creatinine > 2.5 mg/dl, 1 case),
hyperparasitaemia (> 5% parasitized erythrocytes, 2
cases), and jaundice (1 case). Geometric mean parasite
density (GMPD) was 4,449/μl in all 28 patients and
2,673/μl and 22,315/μl in uncomplicated and compli-
cated malaria cases, respectively (p = 0.01). Demo-
graphic, clinical and biochemical characteristics of
malaria cases and healthy controls are shown in Table 1.
Cardiac function
Mean arterial blood pressure was comparable with 86
mmHg and 84 mmHg in malaria cases and controls,
respectively (P = 0.7). Heart rate was significantly higher
in malaria patients than in controls (86/min versus 70/
min, P < 0.001; Table 2). Both, cardiac index (CI) and
stroke index (SI) were highly significantly reduced in
malaria patients compared to controls (CI: 2.7 l/min/m
2
versus 3.4 l/min/m
2, P < 0.001; SI 31.3 ml/m
2 versus
43.6 ml/m
2, P < 0.001, respectively). The systemic vascu-
lar resistance index (SVRI), in contrast, was significantly
elevated in malaria patients (cases: 32.6, controls 23.2, P
< 0.001). Cardiac function parameters did not differ sig-
nificantly between uncomplicated and complicated
malaria cases (see Table 2).
Cardiac enzymes
Findings on cardiac function were paralleled by differ-
ences in cardiac enzymes. All cardiac proteins except for
TnT were about twice as high in malaria patients com-
pared to controls albeit at borderline statistical signifi-
cance for NT proBNP and myoglobin (Table 3). Logistic
(multiple) regression analysis showed that cardiac pro-
teins were elevated in malaria patients independent of
creatinine levels. Levels of cardiac proteins were incon-
sistent in patients with uncomplicated and complicated
malaria: While NT proBNP, myoglobin and H-FABP
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level of CK-MB in complicated malaria was comparable
with the level in healthy controls.
Cytokine analysis
To explore potential pathophysiologic causes for cardiac
impairment in patients with malaria associations
between cardiac function parameters and cardiac pro-
teins with parasite densities and several cytokines repre-
sentative for pro- and anti-inflammatory immune
stimulation were assessed. Neither cardiac function (CI,
SI) and systemic vascular resistance (SVRI) nor cardiac
enzymes were associated with parasite levels (data not
shown). Cytokine levels of malaria cases and controls as
well as patients with uncomplicated and complicated
malaria are summarized in Table 4. All pro- or anti-
inflammatory cytokines assessed were markedly elevated
in malaria patients compared to controls. All cytokines
except for IFN-g indicated a positive correlation with CI
and a negative correlation with the SVRI albeit not
always statistically significant (Figure 1). There was no
association between CI, SI or SVRI with neither haemo-
globin nor creatinine levels.
Discussion
The results presented here show impaired myocardial
function in patients with imported P. falciparum
m a l a r i a .C a r d i a co u t p u t( C O )r e p r e s e n t i n gt h eb l o o d
volume pumped per minute was significantly decreased
in malaria patients compared to healthy controls. The
increase in heart rate, however, was not sufficient to
compensate for the lower stroke volume in malaria
patients. This finding is in line with recent publications
supporting evidence for cardiac dysfunction in malaria
patients [4,12].
Reasons for impaired cardiac function may be related
to impaired pre- or postcardial circulatory parameters
or result from myocardial dysfunction itself. In recent
years, intravascular fluid depletion has been shown to be
present in patients with severe malaria contributing to
at least those pathophysiological processes related to
impaired microcirculation [16]. In patients with malaria
studied here, blood pressure was not affected in either
direction. Moderate volume depletion may be present
and contribute to reduced CO by reducing the pre-load.
This pathophysiological background, however, does not
seem to be the most prominent reason for reduced CO
in the patient group. Except for malaria infection, all
patients were otherwise healthy and well nourished.
There were no differences in cardiac function para-
meters between complicated and uncomplicated malaria
cases which may be due to the fact that comparatively
broad criteria were used to define complicated malaria
and none of the complicated cases was life-threatening.
Table 1 Demographic, clinical and biochemical characteristics of malaria cases on hospital admission and healthy
controls
Malaria cases Uncomplicated cases Complicated cases Healthy controls P-value*
n =2 8 n =2 1 n =7 n =2 6
Age (± SD) 44.0 (± 11,8) 42.1 (± 10.2) 49.3 (± 15.3) 31.2 (± 15,4) 0.001
Male sex (%) 17/28 (61) 13/21 (62) 4/7 (57) 10/26 (38) 0.1
Temperature, °C (± SD) 37.9 (± 1.0) 38.1 (± 1.0) 37.7 (± 1.1) 36.5 (± 0.4) < 0.001
Respiratory rate,/min (± SD) 17 (± 4) 16 (± 4) 19 (± 5) 17 (± 1) 0.7
Haemoglobin, g/l (± SD) 12,8 (± 1.7) 12.7 (± 1.8) 13.0 (± 1.6) 13,6 (± 1.1) 0.07
Thrombocytes, bn/l (± SD) 64,8 (± 39,6) 73,4 (± 38,7) 40,4 (± 33,2) 252,3 (± 102,9) < 0.001
LDH, U/l (± SD) 334 (± 113) 298 (± 97) 425 (± 100) 149 (± 23) < 0.001
Total bilirubin, mg/dl (± SD) 2.7 (± 4.2) 1.3 (± 0.4) 5.9 (± 7.1) 0.6 (± 0.4) 0.02
Creatinine, mg/dl (± SD) 1.1 (± 0.5) 1,04 (± 0.4) 1.4 (± 0.6) 0.8 (± 0.1) 0.003
*comparison between malaria cases (all) and healthy controls (by Mann-Whitney U-test)
Table 2 Cardiac function parameters of malaria cases and healthy controls
Malaria cases Uncomplicated cases Complicated cases Healthy controls P-value*
n =2 8 n =2 1 n =7 n =2 6
MAP, mmHg (± SD) 86 (± 11) 86 (± 12) 86 (± 10) 84 (± 13) 0.7
Heart rate,/min (± SD) 86 (± 14) 87 (± 13) 83 (± 16) 70 (± 8) < 0.001
CI, l/min/m
2 (± SD) 2.7 (± 0.9) 2.7 (± 0.9) 2.9 (± 0.6) 3.4 (± 0.3) < 0.001
SI, ml/m
2 (± SD) 31.3 (± 8.2) 30.3 (± 8.7) 34.2 (± 6.3) 43.6 (± 4.9) < 0.001
SVRI, mmHg m
2/(l/min) (± SD) 32.6 (± 10.3) 33.8 (± 11.0) 29.2 (± 7.2) 23.2 (± 5.2) < 0.001
MAP = mean arterial blood pressure; CI = cardiac index; SI = stroke index; SVRI = systemic vascular resistance index
*comparison between malaria cases (all) and healthy controls (by Mann-Whitney U-test)
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in severe malaria in endemic countries: Children carry-
ing the major burden of severe malaria are at high risk
for rapid fluid loss due to relatively high body surface
combined with high fever as well as additional risk fac-
tors like diarrhoea, high environmental temperatures,
and possibly limited access to effective fluid uptake.
By the methodological approach used in this study, it
was possible to calculate peripheral vascular resistance
which was significantly increased in patients with
malaria. This may indicate that in this patient group
increased after-load might contribute to the decreased
CO. Major pathophysiological processes typical for P. fal-
ciparum malaria are the parasite adhesion to the
endothelium, rosetting, the sequestration of parasitized
and unparasitized red blood cells (RBC) in peripheral
small vessels, and the decreased deformability of RBCs
resulting in impaired microcirculation and lactic acidosis
[9,17-21]. The cytoadherence and rosetting properties of
parasitized erythrocytes have been shown to significantly
increase flow resistance in a recent numerical hemody-
namic analysis [22]. It was not possible to assess the
amount of sequestration in these malaria patients. Car-
diac output, however, did not correlate with blood para-
site levels. This does not rule out an association of
increased after-load with parasite sequestration in the
periphery as parasitaemia assessed from large central
veins does not necessarily correlate with parasite num-
bers sequestered in small vessels and capillaries [23].
Interestingly, significantly elevated levels of d-dimer, a
degradation product of cross-linked fibrin, were present
in this patient group indicating increased fibrinolytic
activity in malaria. D-dimer correlated positively with
CO. Coagulation processes may contribute to both,
thrombocytopenia and impaired microcirculation. Never-
theless, increased peripheral resistance due to parasite-
related increased flow-resistance may not be sufficient to
significantly affect cardiac function. It is likely that our
findings on reduced cardiac output are based on several
co-occurring and interdependent factors like reduced
preload and impaired myocardial function.
Finally, malaria may affect cardiac function itself. NT-
proBNP is a sensitive marker for impaired left ventricu-
lar (LV) function and is significantly elevated predomi-
nantly in severe malaria patients [2,3]. Parasite toxins or
host immune mediators or both may have a suppressive
effect on myocardial function. It has been shown that
the plasmodial toxin glycosylphosphatidylinositol (GPI)
augments apoptosis rates in cardiomyocyte culture
[24,25]. On the other hand, the host immune reaction
against malaria parasites involves pro- and anti-inflam-
matory cytokines as well as immune mediators like
nitric oxide (NO). While pro-inflammatory cytokines
and immune mediators have been shown to exert a sup-
pressive effect on myocardial function, cardiovascular
biomarkers have been reported as good prognostic mar-
kers for outcome in septic and critically ill patients
[6,26]. Recent publications support myocardial
Table 3 Cardiac proteins in malaria cases and healthy controls
Malaria cases Uncomplicated cases Complicated cases Healthy controls P-value*
n =2 8 n =2 1 n =7 n =2 6
NT-proBNP, ng/ml (± SD) 139.3 (± 146.6) 117.7 (± 140.3) 231.1 (± 156.2) 60.4 (± 48.2) 0.07
CK-MB, ng/ml (± SD) 21.5 (± 36.9) 24.0 (± 40.7) 10.8 (± 6.1) 12.1 (± 10.3) 0.08
Myoglobin, mg/l (± SD) 43.6 (± 12.5) 42.9 (± 12.0) 45.4 (± 15.0) 27.8 (± 15.0) < 0.001
TnT, ng/ml (± SD) < 0.1 (na) < 0.1 (na) < 0.1 (na) < 0.1 (na) ns
H-FABP, ng/ml (± SD) 1.9 (± 1.1) 1.7 (± 1.0) 2.7 (± 1.0) 1.1 (± 1.6) < 0.01
NT-proBNP = N-terminal pro-brain natriuretic peptide; CK-MB = creatine kinase-muscle brain; TnT = troponin T; H-FABP = heart-type fatty acid-binding protein
*comparison between malaria cases (all) and healthy controls (by Mann-Whitney U-test)
Table 4 Cardiac proteins in malaria cases and healthy controls
Malaria cases Uncomplicated cases Complicated cases Healthy controls P-value*
n =2 8 n =2 1 n =7 n =2 6
IL-2, pg/ml (± SD) 1.3 (± 1.5) 1.1 (± 1.3) 2.2 (± 1.9) 0.5 (± 0.9) 0.04
IL-6, pg/ml (± SD) 33.8 (± 45.0) 36.8 (± 49.8) 21.0 (± 7.5) 5.0 (± 9.0) < 0.001
TNF, pg/ml (± SD) 2.6 (± 1.7) 2.4 (± 1.8) 3.4 (± 1.0) 1.5 (± 0.7) 0.002
IFN-g, pg/ml (± SD) 4.9 (± 5.5) 3.3 (± 2.2) 11.6 (± 10.1) 1.9 (± 0.7) < 0.001
IL-17A, pg/ml (± SD) 35.7 (± 29.6) 26.9 (± 16.9) 72.9 (± 45.2) 21.0 (± 9.7) 0.02
IL-4, pg/ml (± SD) 2.7 (± 1.6) 2.4 (± 1.5) 3.9 (± 1.5) 1.3 (± 1.1) 0.001
IL-10, pg/ml (± SD) 246.4 (± 366.8) 256.2 (± 404.7) 204.4 (± 142.7) 2.0 (± 0.8) < 0.001
UM = uncomplicated malaria; CM = complicated malaria
*comparison between malaria cases (all) and healthy controls (by Mann-Whitney U-test)
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is still contradictory [29]. In addition, anti-malarial treat-
ment may add to cardiotoxic effects [30].
To assess the influence of the host immune reaction, a
series of pro- and anti-inflammatory cytokines was
assessed. As anticipated, all cytokines assessed were sig-
nificantly elevated in malaria patients compared to con-
trols, especially IL-17A in complicated malaria (Table
4). Their association with cardiac function parameters,
however, was inconsistent. Most pro- and anti-inflam-
matory cytokines except for IFN-g were associated with
increased cardiac output on the one hand and decreased
peripheral vascular resistance on the other (see Figure
1). It has been described that pro-inflammatory cyto-
kines like TNF-a have can impact myocardial function
v i an e g a t i v e - i n o t r o p i ce f f e c t sw h i c hm a yp l a yar o l ei n
malaria patients [31]. The study design was not designed
to explore the role of these cytokines any further or to
discriminate between Th1-, Th2-, or Th17 cytokines
with respect to cardiac function. If elevated cytokines
represent activated host immunity in general, this seems
to have an overall influence on cardiac function in
malaria similar to the hyperdynamic but haemodynami-
cally inefficient status described in bacterial sepsis
[5-7,32,33]. In a subset of patients, however, pathogenic
features characteristic for malaria resulting in impaired
microcirculation may outweigh this effect related to
unspecific host immune defence mechanisms. While
high-output failure is typical for bacterial sepsis and
high fluid substitution as been long established as life-
saving therapy, pathophysiological processes appear to
be more heterogenic in malaria leading to (mild) low-
output failure at least in a subset of patients. Yet, find-
ings could be interpreted in that moderate and careful
volume substitution may be preferable over strict
volume depletion in this highly febrile disease as it may
not only improve cardiac output but also may have a
beneficial effect on microcirculation, tissue perfusion
and lactic acidosis. However, there is no evidence
derived from randomised clinical trials that volume sub-
stitution improves mortality in severe malaria.
The present study has some limitations. A rather
small patient population was assessed which increases
the risk of type I errors. Furthermore, the study popula-
tion was rather heterogeneous in that pathophysiological
processes may differ in German travellers and African
migrants. All African migrants, however, had lived in
Germany for at least two years and persistent semi-
immunity was unlikely to have a major influence on the
findings presented here. Finally, one substantial limita-
tion results from the unmatched control group despite
the fact that respective cardiac function parameters were
expressed as indices to correct for differences in body
weight and height.
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allowed the assessment of several dynamic functional
parameters. As it is usually not indicated or possible to
assess cardiovascular function by the gold standard of
invasive thermodilution techniques our findings may
contribute to the existing evidence on cardiovascular
function in malaria patients. To obtain further informa-
tion on the cardiovascular system in patients with
malaria a larger scale trial on cardiac function in chil-
dren with severe malaria is currently being completed in
hyper-endemic regions of Ghana.
Conclusions
Findings presented here support previous reports sug-
gesting impaired cardiac function contributing to clinical
manifestations in P. falciparum malaria. Reduced cardiac
output is paralleled by increased systemic vascular resis-
tance. Findings may be relevant for fluid management
and should be further explored in endemic regions.
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